Kaplan-Meier estimate and the log-rank test showed that patients with a pJNK-negative (JNK inactive) and pFOXO1-negative (FOXO1 active) tumor had significantly worse outcome than those with other combinations (P < 0.001) (Fig. 5a). The gene discussed is FOXO1; the disease is neoplasm.